Birchview Capital, LP 10x Genomics, Inc. Transaction History
Birchview Capital, LP
- $100 Million
- Q2 2024
A detailed history of Birchview Capital, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Birchview Capital, LP holds 30,000 shares of TXG stock, worth $704,400. This represents 0.58% of its overall portfolio holdings.
Number of Shares
30,000
Previous 30,000
-0.0%
Holding current value
$704,400
Previous $1.13 Million
48.18%
% of portfolio
0.58%
Previous 0.97%
Shares
4 transactions
Others Institutions Holding TXG
# of Institutions
284Shares Held
96.2MCall Options Held
162KPut Options Held
107K-
Vanguard Group Inc Valley Forge, PA10.2MShares$239 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.31MShares$219 Million1.65% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$150 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.15MShares$144 Million1.4% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.14MShares$144 Million0.09% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $2.23B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...